[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis]. Bazinski H, Jensen H B, Stenager E Ugeskr Laeger. 2015 May 11; 177(20):956-60. PMID: 26535431. Abstract CommentRecommendBookmarkWatch